Pfizer received a flurry of attention toward the end of November as its blockbuster statin Lipitor came to the end of its patent protection. Many media outlets were impressed with Pfizer’s aggressive, ...

TRENTON, N.J. -- Pfizer Inc., the world's biggest drug company, is laying off up to 800 scientists this year in its latest effort to refocus disappointing research efforts and cut its massive overhead ...

With it exclusive window on cholesterol drug Lipitor long closed, Pfizer is looking to the post-Lipitor world. WSJ's Spencer Jakab visits Mean Street to make the case that the company's future is ...

Pfizer (NYSE: PFE) is no stranger to income investors. The drugmaker, famous for treatments including Lipitor, Viagra, and Zoloft, has now increased its dividend payout for 16 consecutive years. And ...

WASHINGTON -- Pfizer Inc. announced Monday it is pulling its Lipitor advertisements that feature the inventor of the artificial heart whose endorsement came under congressional fire earlier this year.

NEW YORK (AP) -- Pfizer Inc. won a crucial court ruling Friday that will allow it to exclusively sell the top-selling drug worldwide, the cholesterol-lowering drug Lipitor, until 2011. Shares of ...

The $68 billion acquisition will solidify Pfizer’s standing as the top-selling drugmaker. Bottles of Pfizer’s Lipitor, left, and Wyeth’s Effexor are shown. Shareholders of Wyeth voted overwhelmingly ...

A study backed by the German government has found no evidence to suggest that the cholesterol-fighting statin Lipitor is any more effective than rival drugs. The study, which was conducted by an ...

Drug maker Pfizer Inc. reported a 25% increase in second-quarter profit, as lower expenses helped cushion sales erosion from the loss of U.S. market exclusivity for blockbuster cholesterol-lowering ...